SN-38

About Haorui Products Technology Contact

SN-38 (7-ethyl-10-hydroxycamptothecin ) API

 

Haorui supplies high quality SN-38 API produced by our GMP facility that has been successfully inspected by the FDA. We offer competitive prices and support our products with reliable technical and regulatory services.  SN-38 API is available from R&D to commercial quantities. Please contact us for more details.

The following information is provided for general information purposes ONLY.

SN-38 Description
SN-38 is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor); it is 200 times more active than irinotecan itself.

SN38 is metabolized via glucoronidation by UGT1A1.

The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolization of Irinotecan predicts Irinotecan toxicity, as it cannot be excreted from the body in its SN-38 form.

SN-38 is lost into the bile and feces. It can cause the symptoms of diarrhoea and myelosuppression experienced by ~25% of the patients administered Irinotecan.

Chemical Structure

Molecular Formula C22H20N2O5

SN-38 Clinical Trials 1

SN-38 Clinical Trials 2

SN-38 Clinical Trials 3

SN-38 Clinical Trials 4

SN-38 Patents 1

SN-38 Patents 2

SN-38 Patents 3

SN-38 Patents 4

Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved